Evidence map›Paper›PMID 42741992›Full record

ReviewChemistry & biodiversity2026

Heterocyclic-Based Fungicides: Emerging Strategies for Viable Plant Disease Control.

Sumit Tahlan, Meenakshi Kaira, Sucheta Singh, Hrithik Dey, Kailash C Pandey

Abstract readReview
In one paragraph

Review in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sumit TahlanICMR-National Institute of Malaria Research, New Delhi, India.ORCID https://orcid.org/0000-0002-6775-8663
Meenakshi KairaLloyd Institute of Management and Technology, Greater Noida, Uttar Pradesh, India.
Sucheta SinghDepartment of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India.
Hrithik DeyLloyd Institute of Management and Technology, Greater Noida, Uttar Pradesh, India.ORCID https://orcid.org/0009-0000-6196-1911
Kailash C PandeyICMR-National Institute of Malaria Research, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal infections in plants cause significant agricultural losses worldwide, while increasing fungicide resistance and growing environmental concerns have created an urgent need for safer and more effective antifungal agents. Heterocyclic compounds have attracted considerable attention because of their structural diversity, potent antifungal activity, and ability to interact with multiple fungal targets, offering broad-spectrum protection against phytopathogens. This review summarizes the classification of heterocyclic fungicides, their mechanisms of action targeting fungal cells and enzymes, and their potential for controlling major plant fungal diseases. It also highlights recent advances in the rational design, synthesis, molecular docking, and SAR studies of heterocyclic scaffolds, along with molecular optimization strategies to overcome resistance and improve efficacy and bioavailability. Furthermore, the review emphasizes the potential of heterocyclic moieties for the development of environmentally sustainable plant protection agents. Synthetic and semisynthetic/part-natural scaffolds, particularly azole, quinoline, indole, cyclotryptamine, and phenazine derivatives, demonstrated promising antifungal activity, with structural optimization further enhancing their efficacy and identifying them as valuable lead candidates for next-generation sustainable fungicides.

Indexed as

Antifungal AgentsFungiFungicides, IndustrialHeterocyclic CompoundsPlant DiseasesMolecular StructurePlantsStructure-Activity RelationshipAntifungal AgentsFungicides, IndustrialHeterocyclic Compoundsheterocyclic scaffoldsphytopathogenic fungiplant fungicidesSARschemes

Identifiers

PMID42741992
PMCPMC13575950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.